882689-03-4

Upstream product

• 42926-89-6 1,2-O-isopropylidene-3-O-benzyl-α-D-glucofuranose 
• 98-88-4 benzoyl chloride 
• 124-63-0 methanesulfonyl chloride 
• 582-52-5 1,2:5,6-diacetone-D-glucose 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 

Downstream Products

• 868078-60-8 (3aR,5R,6S,6aR)-6-Benzyloxy-2,2-dimethyl-5-oxiranyl-tetrahydro-furo[2,3-d][1,3]dioxole 
• 66963-60-8 1,6-anhydro-3-O-benzyl-β-D-glucopyranose 
• 498-07-7 levoglucosan 
• 23567-05-7 1,6-Anhydro-2,3,4-tri-O-benzoyl-β-D-glucopyranose 
• 334834-19-4 1,6-anhydro-2-O-benzoyl-3-O-benzyl-β-L-idopyranoside 
• 918948-22-8 (1S,2R,3S,4R,5S)-3,4-Bis-benzyloxy-6,8-dioxa-bicyclo[3.2.1]octan-2-ol 

Relevant academic research and scientific papers

PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY

Hypersulfated disaccharides with utility in asthma or asthma related disorders are disclosed. The heptasulfated disaccharides administered orally have comparable bioavailability to the intravenous administered dosage form.

DISACCHARIDE COMPOUNDS

Disaccharide compounds used as building blocks for making heparin and heparan sulfate oligosaccharides. Also disclosed are methods for making these disaccharide compounds.

Heparin oligosaccharides

The present invention provides composition and methods for the synthesis of low molecular weight heparins and heparinoids. The present invention also provides compositions having substantially homogenous populations of desired heparin molecules, or molecu